← Back to Bills
HR 10058118th CongressFailed / ExpiredHouse

Medicaid Breast Cancer Access to Treatment Act

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Aug 15, 2025
Latest Action Date
Oct 25, 2024

Latest Action

Referred to the House Committee on Energy and Commerce.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Medicaid Breast Cancer Access to Treatment Act (H.R. 10058) was a bill introduced in the 118th Congress aimed at addressing access to breast cancer treatment for Medicaid beneficiaries. The bill was referred to the House Committee on Energy and Commerce but did not advance further and ultimately failed or expired. Specific provisions, funding mechanisms, or detailed legislative text are not available in the provided data.

Bottom Line

H.R. 10058 sought to improve Medicaid coverage for breast cancer treatment but did not progress beyond committee referral and expired without enactment.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill focused on Medicaid and breast cancer treatment access.
  • It was introduced in the House during the 118th Congress and referred to the House Committee on Energy and Commerce.
  • The bill did not advance past committee and is listed as failed or expired.
Who Benefits?

['Medicaid beneficiaries diagnosed with breast cancer', 'Healthcare providers offering breast cancer treatment to Medicaid patients', 'Potentially state Medicaid programs managing breast cancer treatment coverage']

Potential Concerns

['Lack of detailed bill text limits understanding of specific provisions and funding sources', 'No information on oversight or enforcement mechanisms is available', 'Potential cost implications for Medicaid programs are unknown', 'Unclear how the bill would interact with existing Medicaid policies or state-level variations']

Political Context

The bill was introduced in the House during the 118th Congress and referred to the House Committee on Energy and Commerce, a committee with jurisdiction over health policy. The bill did not advance beyond committee referral and is recorded as failed or expired, indicating it did not receive a floor vote or enactment during the congressional session.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['Potential increase in Medicaid expenditures if the bill expanded coverage or treatment requirements', 'Possible changes in healthcare provider practices related to breast cancer treatment for Medicaid patients', 'State Medicaid programs might need to adjust policies or budgets to comply if the bill had passed']

GovScope Watchdog Notes

The absence of the full bill text and official summary limits transparency and public understanding of the bill's specific provisions and impacts. The bill's failure to advance beyond committee referral suggests limited legislative momentum. Oversight considerations include the need for clear funding sources and enforcement mechanisms to ensure effective implementation if similar legislation is proposed in the future.

Passage Likelihood: LowConfidence: 70%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready